Korean healthcare and medical devices in Saudi Arabia: a guide
- Saudi healthcare is being restructured under Vision 2030, creating demand from public and private providers
- Every medical device needs SFDA marketing authorization (MDMA), and overseas makers act through a Saudi Authorized Representative
- Public hospital supply largely runs through NUPCO and government tenders; private hospitals and clinics buy directly
- A capable local partner, clean regulatory files and training support usually decide success
Korea has built a strong reputation in healthcare: advanced hospitals, competitive medical devices, a world-famous aesthetic sector, and fast-moving digital health. Saudi Arabia, meanwhile, is reshaping how its health system is organised, financed and delivered. For Korean companies in devices, diagnostics, aesthetic equipment, health IT and pharmaceuticals, that combination opens real opportunities, but the Saudi market is regulated and relationship-driven.
This guide summarises how the sector is changing, how SFDA medical device registration works, how public and private buyers purchase, and how Korean companies typically partner with Saudi providers. Rules evolve, so confirm current requirements with the authorities before you plan timelines.
The health sector transformation, in brief
Under Vision 2030, Saudi Arabia runs a Health Sector Transformation Program that aims to improve access, quality and efficiency, expand prevention and digital care, and increase private-sector participation. Public hospitals and primary care centres have been organised into regional health clusters under a government-owned health holding company, while the Ministry of Health (MOH) focuses more on regulation and oversight. Privatisation and public-private partnership projects are also part of the plan.
The details and pace of these reforms are still developing, and announcements change over time. What matters for suppliers is the direction: more structured procurement, more attention to outcomes and value, growing private hospitals and clinics, and strong interest in digital health and local manufacturing.
Where Korean strengths fit
- Medical devices: imaging, ultrasound, patient monitoring, surgical instruments, dental implants and equipment
- In-vitro diagnostics: test kits, analysers and point-of-care devices
- Aesthetic devices: lasers, HIFU, radiofrequency and other energy-based systems, plus fillers and related products
- Digital health: hospital information systems, PACS, telemedicine, AI-assisted diagnosis and wearables
- Pharmaceuticals and biosimilars, where localisation is a stated national priority
- Hospital operations, training and specialised clinical services through partnerships
SFDA medical device registration: MDMA and the Authorized Representative
The Saudi Food and Drug Authority (SFDA) regulates medical devices, including in-vitro diagnostics and many aesthetic devices. Before a device can be placed on the Saudi market, it generally needs a Medical Device Marketing Authorization (MDMA), whatever its risk class. An overseas manufacturer cannot usually apply alone: it appoints a Saudi-based Authorized Representative (AR), licensed by SFDA, under a written mandate. SFDA guidance indicates a manufacturer should have only one AR for the same device.
- Manufacturer account: the Korean manufacturer creates an overseas manufacturer account on SFDA's electronic services
- Authorized Representative: a Saudi entity holding the relevant SFDA licence and acting under a signed mandate
- Technical file: device description, classification, labelling and instructions for use, quality system evidence such as ISO 13485, clinical and performance data
- Prior approvals: SFDA has historically relied on approvals from reference jurisdictions (the US, EU, Canada, Australia and Japan); Korea's MFDS approval alone has not traditionally been one of them, and recent changes are reported, so confirm the current pathway for your device
Many Korean manufacturers already hold CE marking or FDA clearance, which often makes the Saudi file easier to build. Our SFDA medical device registration page explains the steps in more detail.
Establishment licensing and post-market duties
Importers, distributors and storage facilities need their own SFDA establishment licences. After approval, the AR and manufacturer share post-market responsibilities: complaint handling, adverse-event reporting, field safety notices and recalls, and cooperation with SFDA surveillance. SFDA also has device identification and labelling requirements, including language rules for labels and instructions, so plan Arabic content early, especially for devices used by patients at home.
Pharmaceuticals and the localisation agenda
Medicines are registered separately with SFDA, with requirements for quality, safety, efficacy, manufacturing standards and pricing. Saudi Arabia has made pharmaceutical and vaccine localisation a priority, and the Local Content and Government Procurement Authority (LCGPA) applies local content mechanisms in government purchasing. For Korean pharma and biosimilar companies, this can favour technology transfer, contract manufacturing or joint ventures with Saudi producers over pure import. See our local content certificate and industrial license pages.
Digital health and software
Digital health has a high profile in Saudi Arabia, with virtual care services, national health apps and data exchange platforms. Korean health IT companies should check three areas early:
- Software as a medical device: software with a medical purpose can fall under SFDA device regulation and need MDMA
- Data protection: the Personal Data Protection Law, overseen by the Saudi Data and AI Authority (SDAIA), covers health data, including rules on transfers abroad
- Cybersecurity and hosting: public-sector clients usually expect compliance with National Cybersecurity Authority (NCA) controls and may require local hosting
Integration with hospital systems and insurance platforms is often what buyers ask about first, so prepare interoperability information and Arabic-capable interfaces. Our technology sector page covers licensing for tech companies.
Public hospitals and procurement: NUPCO and Etimad
The National Unified Procurement Company (NUPCO) purchases medicines, medical supplies and devices for many public health providers, often through framework agreements and tenders. Suppliers typically register on NUPCO's platform and products must already be registered with SFDA. Other government entities publish tenders on Etimad, the government procurement platform.
- Register with SFDA first; procurement registration usually depends on it
- Expect local content requirements and price preferences for local products in government purchasing
- Tender documents are usually in Arabic, with strict deadlines and formats
- After-sales service, spare parts and training capacity inside Saudi Arabia are often evaluated
Supplier registration is easier when your Saudi entity or partner already has a commercial registration, VAT registration and a national address in order. See our supplier and vendor registration page.
Private hospitals, clinics and the aesthetic market
Private hospital groups and specialised clinics buy directly, usually through distributors who provide installation, training and maintenance. Dermatology and aesthetic clinics form an active segment, and Korean devices and techniques are well known among practitioners, much like Korean skincare (see our K-beauty guide).
- Energy-based aesthetic devices such as lasers, HIFU and RF systems are regulated as medical devices and need MDMA
- Products such as fillers and botulinum toxins fall under SFDA device or drug rules, depending on the product
- Clinics are licensed by MOH and practitioners are registered with the Saudi Commission for Health Specialties (SCFHS)
- Advertising of medical and aesthetic products is regulated; avoid unapproved claims
Partnering with Saudi providers
Most Korean healthcare companies enter through partnership rather than going it alone at first. Common models:
| Model | Suits | Key point |
|---|---|---|
| Distributor plus Authorized Representative | Device and IVD makers starting out | Keep regulatory ownership clear; the AR and the distributor can be different companies |
| Own Saudi entity | Companies with steady volumes or service needs | Requires a MISA licence and commercial registration; see our MISA guide |
| Joint venture or local manufacturing | Pharma, consumables, larger device makers | Supports local content and long-term procurement access |
| Clinical, training or operations partnership | Hospitals, specialised clinics, health IT | Licensing of practitioners and data rules must be planned |
Trade shows such as the Global Health Exhibition in Riyadh are a common place to meet Saudi providers and distributors; our business trips and exhibitions page covers trip planning.
How RDO helps
RDO coordinates the Saudi side of your healthcare market entry: mapping SFDA requirements for your devices or products, preparing documents and following up on registration steps through licensed parties, supporting supplier registration, and helping you find and screen distributors and partners. We can also handle company formation if you set up your own entity. We work in Arabic, English and Chinese; with Korean teams we communicate in English and arrange certified translation when required. See also Korean companies in Saudi Arabia and our Korea-Saudi business page.
Frequently asked questions
Is Korean MFDS approval enough to sell in Saudi Arabia?
Usually not on its own. SFDA issues its own MDMA and has historically looked for approvals from certain reference jurisdictions. Requirements are evolving, so confirm the current pathway for your device class.
Do we need our own Saudi company to register a device?
No. An overseas manufacturer can appoint a licensed Saudi Authorized Representative. An own entity helps later for service, tenders and local presence.
How do we sell to government hospitals?
Typically through NUPCO registration and tenders or Etimad, after SFDA registration, often with a local partner that provides service and support.
Are aesthetic lasers treated as medical devices?
Generally yes. Energy-based aesthetic systems need SFDA authorization, and clinics using them must be properly licensed.
Need help with this in Saudi Arabia?
Tell us about your company and we will map the exact steps, documents and timeline for you. The first consultation is free.
Chat on WhatsApp